Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Evolus (EOLS) Research & Development: 2018-2025

Historic Research & Development for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Evolus' Research & Development fell 11.58% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 6.54%. This contributed to the annual value of $9.2 million for FY2024, which is 39.90% up from last year.
  • Per Evolus' latest filing, its Research & Development stood at $2.0 million for Q3 2025, which was up 11.38% from $1.8 million recorded in Q2 2025.
  • In the past 5 years, Evolus' Research & Development ranged from a high of $2.4 million in Q4 2024 and a low of $301,000 during Q3 2021.
  • For the 3-year period, Evolus' Research & Development averaged around $2.0 million, with its median value being $2.1 million (2024).
  • Examining YoY changes over the last 5 years, Evolus' Research & Development showed a top increase of 357.14% in 2022 and a maximum decrease of 44.35% in 2022.
  • Quarterly analysis of 5 years shows Evolus' Research & Development stood at $423,000 in 2021, then skyrocketed by 218.68% to $1.3 million in 2022, then surged by 76.56% to $2.4 million in 2023, then climbed by 2.10% to $2.4 million in 2024, then decreased by 11.58% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.8 million for Q2 2025, and $2.2 million during Q1 2025.